Immutep (Immutep) Total Assets : $82.86 Mil (As of Dec. 2023)

View and export this data going back to 1988. Start your Free Trial

What is Immutep Total Assets?

Immutep's Total Assets for the quarter that ended in Dec. 2023 was $82.86 Mil.

During the past 12 months, Immutep's average Total Assets Growth Rate was 13.70% per year. During the past 3 years, the average Total Assets Growth Rate was 5.80% per year. During the past 5 years, the average Total Assets Growth Rate was -0.10% per year. During the past 10 years, the average Total Assets Growth Rate was 19.60% per year.

During the past 13 years, Immutep's highest 3-Year average Total Assets Growth Rate was 118.50%. The lowest was -3.70%. And the median was 5.40%.

Total Assets is connected with ROA %. Immutep's annualized ROA % for the quarter that ended in Dec. 2023 was 0.00%. Total Assets is also linked to Revenue through Asset Turnover. Immutep's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

Immutep Total Assets Historical Data

The historical data trend for Immutep's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immutep Total Assets Chart

Immutep Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Assets

Get a 7-Day Free Trial

28.15

32.16

62.72

71.80

98.96

Immutep Quarterly Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															-	98.96	-	82.86	-

Immutep Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Immutep's Total Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (A: Jun. 2023 )	+	Total Liabilities (A: Jun. 2023 )
	=	91.59	+	7.369
	=	98.96

Immutep's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	77.405	+	5.452
	=	82.86

Immutep (NAS:IMMP) Total Assets Explanation

Total Assets is connected with ROA %.

Immutep's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	0	/	( (0	+	82.857)	/ 1 )
	=	0	/	82.857
	=	0.00 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Immutep's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0	/	( (0	+	82.857)	/ 1 )
=	0	/	82.857
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Immutep Total Assets Related Terms

Thank you for viewing the detailed overview of Immutep's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Immutep (Immutep) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immutep Ltd (NAS:IMMP) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

PRRUF:USA YP1B:Germany IMM:Australia

Address

264 George Street, Level 33, Australia Square, Sydney, NSW, AUS, 2000

Website

https://www.immutep.com

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trails, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia and derives the majority of the revenue from the sale of the products.